Despite growing awareness of the benefits of exercise, adolescents face persistent barriers to regular activity, with girls ...
Ontario sent letters to hundreds of family doctors over a “high number” of workdays, but critics say billing data can’t ...
Casual conversation can mask early dementia. To catch impairment, geriatric experts urge primary care clinicians to adopt ...
Omalizumab (Xolair) may reduce allergic reactions and the need for emergency epinephrine in patients with alpha-gal syndrome ...
An estimated 230 million girls and women live with the consequences of FGM. Clinicians can help identify those affected or at ...
Doctors Condemn Prediction Markets on Clinical Trial Outcomes, Warning of Threats to Trial Integrity
Kalshi's pilot lets users wager on late-stage trial results. Physicians and researchers say the markets threaten trial ...
The rate of influenza visits reached 140.6 encounters per 100,000 patients in mid-September across office, emergency ...
The FDA has granted accelerated approval to the kinase inhibitor neladalkib (Nelkarmi, Nuvalent) for adults with locally advanced or metastatic ALK-positive non-small cell lung cancer who have ...
Two dermatologists involved in longevity medicine agree that the marketing of therapies is overwhelming the evidence even as promising therapies are in development.
Giredestrant plus everolimus significantly outperforms standard endocrine therapy in a post-CDK4/6 inhibitor setting.
Electroacupuncture reduced liver fat and partly restored anti-inflammatory macrophages in mice, offering early signs that ...
Study reports an AI model is as accurate as humans for generating preliminary echocardiogram interpretations, saving time for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results